← Insider buys
RGLS

Regulus Therapeutics Inc.

Growth Equity Opportunities V, LLC bought $2.7M of Regulus Therapeutics Inc.

10% owner

Bought$2,735,930
$0.62Price
4,398,602Shares
+214%Stake

What RGLS did for a copier

Prices for RGLS after this filing aren't in yet.

Growth Equity Opportunities V, LLC's record

1 other buy on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Dec 4. Filed Mon, Dec 7, 12:06 PM ET, during the session. Not investment advice.